Global Proton Pump Inhibitors (PPIs) Market Investigation Indicates Growth in the Coming Years
The report presents precise details about the production and market share to enlighten the readers. Also, the report reveals that, the proton pump inhibitors market would grow at a double-digit CAGR during the period between 2017 and 2022.
(EMAILWIRE.COM, July 08, 2017 ) Proton pump inhibitors are used to relieve symptoms of acid reflux, or gastroesophageal reflux disease. With such effective benefits, the market for these drugs is rising with time. Market Research Hub (MRH) has added a latest report to its repository focusing on the proton pump inhibitors sector. This research study is titled “Global Proton Pump Inhibitors (PPIs) Market Research Report 2017”, which presents precise details about the production and market share to enlighten the readers. Also, the report reveals that, the proton pump inhibitors market would grow at a double-digit CAGR during the period between 2017 and 2022.
Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1174589
Proton pump inhibitors (PPIs) are known as a group of drugs whose primary action is a long-lasting reduction of gastric acid production. Presently, considering the various product types, PPIs are available as Pantoprazole, Lansoprazole, Omeprazole, Rabeprazole and Esomeprazole. This drug category is needed in hospitals and clinics for the treatment of patients suffering from conditions like NSAID, ulcers and esophageal duodenal. Currently, the dominant players from this sector include manufacturers such as AstraZeneca, Janssen, Pfizer, Eisai, Cadila Pharmaceuticals, Santarus
and Eli Lilly.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Proton Pump Inhibitors (PPIs) in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Proton Pump Inhibitors (PPIs) market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including:
AstraZeneca
Pfizer
Janssen
Eisai
Eli Lilly
Cadila Pharmaceuticals
Santarus
Wyeth
Changzhou Siyao Pharmaceuticals
Yangzhou Pharmaceutical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into:
Pantoprazole
Omeprazole
Lansoprazole
Esomeprazole
Rabeprazole
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Proton Pump Inhibitors (PPIs) for each application, including:
Hospitals
Clinics
Other
Browse Full Report with TOC @ http://www.marketresearchhub.com/report/global-proton-pump-inhibitors-ppis-market-research-report-2017-report.html
Table of content:
Global Proton Pump Inhibitors (PPIs) Market Research Report 2017
1 Proton Pump Inhibitors (PPIs) Market Overview
1.1 Product Overview and Scope of Proton Pump Inhibitors (PPIs)
1.2 Proton Pump Inhibitors (PPIs) Segment by Type (Product Category)
1.2.1 Global Proton Pump Inhibitors (PPIs) Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Proton Pump Inhibitors (PPIs) Production Market Share by Type (Product Category) in 2016
1.2.3 Pantoprazole
1.2.4 Omeprazole
1.2.5 Lansoprazole
1.2.6 Esomeprazole
1.2.7 Rabeprazole
1.2.8 Other
1.3 Global Proton Pump Inhibitors (PPIs) Segment by Application
1.3.1 Proton Pump Inhibitors (PPIs) Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Proton Pump Inhibitors (PPIs) Market by Region (2012-2022)
1.4.1 Global Proton Pump Inhibitors (PPIs) Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Proton Pump Inhibitors (PPIs) (2012-2022)
1.5.1 Global Proton Pump Inhibitors (PPIs) Revenue Status and Outlook (2012-2022)
1.5.2 Global Proton Pump Inhibitors (PPIs) Capacity, Production Status and Outlook (2012-2022)
Make an Enquiry @ http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1174589
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of Research Reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Read More Industry News @ https://www.industrynewsanalysis.com/
Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1174589
Proton pump inhibitors (PPIs) are known as a group of drugs whose primary action is a long-lasting reduction of gastric acid production. Presently, considering the various product types, PPIs are available as Pantoprazole, Lansoprazole, Omeprazole, Rabeprazole and Esomeprazole. This drug category is needed in hospitals and clinics for the treatment of patients suffering from conditions like NSAID, ulcers and esophageal duodenal. Currently, the dominant players from this sector include manufacturers such as AstraZeneca, Janssen, Pfizer, Eisai, Cadila Pharmaceuticals, Santarus
and Eli Lilly.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Proton Pump Inhibitors (PPIs) in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Proton Pump Inhibitors (PPIs) market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including:
AstraZeneca
Pfizer
Janssen
Eisai
Eli Lilly
Cadila Pharmaceuticals
Santarus
Wyeth
Changzhou Siyao Pharmaceuticals
Yangzhou Pharmaceutical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into:
Pantoprazole
Omeprazole
Lansoprazole
Esomeprazole
Rabeprazole
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Proton Pump Inhibitors (PPIs) for each application, including:
Hospitals
Clinics
Other
Browse Full Report with TOC @ http://www.marketresearchhub.com/report/global-proton-pump-inhibitors-ppis-market-research-report-2017-report.html
Table of content:
Global Proton Pump Inhibitors (PPIs) Market Research Report 2017
1 Proton Pump Inhibitors (PPIs) Market Overview
1.1 Product Overview and Scope of Proton Pump Inhibitors (PPIs)
1.2 Proton Pump Inhibitors (PPIs) Segment by Type (Product Category)
1.2.1 Global Proton Pump Inhibitors (PPIs) Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Proton Pump Inhibitors (PPIs) Production Market Share by Type (Product Category) in 2016
1.2.3 Pantoprazole
1.2.4 Omeprazole
1.2.5 Lansoprazole
1.2.6 Esomeprazole
1.2.7 Rabeprazole
1.2.8 Other
1.3 Global Proton Pump Inhibitors (PPIs) Segment by Application
1.3.1 Proton Pump Inhibitors (PPIs) Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Proton Pump Inhibitors (PPIs) Market by Region (2012-2022)
1.4.1 Global Proton Pump Inhibitors (PPIs) Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Proton Pump Inhibitors (PPIs) (2012-2022)
1.5.1 Global Proton Pump Inhibitors (PPIs) Revenue Status and Outlook (2012-2022)
1.5.2 Global Proton Pump Inhibitors (PPIs) Capacity, Production Status and Outlook (2012-2022)
Make an Enquiry @ http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1174589
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of Research Reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Read More Industry News @ https://www.industrynewsanalysis.com/
Contact Information:
Market Research Hub
Sudip S
Tel: +1-518-621-2074
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Research Hub
Sudip S
Tel: +1-518-621-2074
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results